The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
| Descrizione | Lingua | Dimensioni | Downloads | |
|---|---|---|---|---|
 |
Abbonati Chemicals
|
EN | 5803 kB | 1 |
This volume of the IARC Monographs provides evaluations of the carcinogenicity of five industrial chemicals: 1,1,1-trichloroethane, 1,2-diphenylhydrazine, diphenylamine, N-me...
ID 18830 | 26.01.2023 / In allegato
L’amianto (o asbesto) è un minerale naturale fibroso, composto da silicati in associazione con altri elementi e m...
Decisione di esecuzione della Commission del 25 novembre 2013 relativa alle linee guida sull’allegato I del regolamento (CE) n. 1223/2009 del Parlamento europeo e del Consiglio su...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024